NCT01900834View on ClinicalTrials.gov

Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Healthy
Interventions
OTHER

No treatment given

The participants will not receive any treatment

Trial Locations (1)

08540

Novo Nordisk Investigational Site, Princeton

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT01900834 - Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period | Biotech Hunter | Biotech Hunter